doi: 10.2478/enr-2018-0002 40 ShojaeianZSadeghiRLatifnejad RoudsariR
Indocyanine green (ICG) is the only NIR fluorescent agent currently approved for human use
Similarly, Australias Therapeutic Goods Administration (TGA) updated prescribing guidelines in 2024 to prioritize high-risk patients as GLP-1 demand increased across both metropolitan and regional health networks, creating a broader global foundation for sustained GLP-1 adoption without relying on repeated data points
Cardiovasc Diabetol 17:62 Correale M, Petroni R, Coiro S, Antohi E-L, Monitillo F, Leone M, Triggiani M, Ishihara S, Dungen H-D, Sarwar CMS, Memo M, Sabbah HN, Metra M, Butler J, Nodari S (in press) Paradigm shift in heart failure treatment: are cardiologists ready to use gliflozins
Post-event recovery sessions work best within 24-48 hours of intense competition or training